The Only Complete AI Solution for Venous Thromboembolism
Improve time-to-treatment and cross-department collaboration while realizing incremental revenue with the only VTE solution that allows you to manage the full spectrum of the disease.
With approximately 900,000 cases diagnosed in the United States each year, venous thromboembolism (VTE) is a common yet underdiagnosed disease that can overburden health systems due to suboptimal outcomes, including low survival rates, long-term complications and recurrence.1, 2
Artificial intelligence has the potential to transform the way VTE care is provided, helping clinicians to quickly coordinate care, accelerate clinical decision making and manage long-term patient follow-up adherence.



















